Main > > Treatment > Co: FR. A. 177Lu Oxodotreotide

---

Co: FR. A. 177Lu Oxodotreotide's subsections
(*) EU Approval Date: 2017. 09.29
(*) USA Approval Date: 2018. 01.26
Companion Diagnostics>
Company
Company ACQ. By:?
Lu: Lutetium
Patent>Assignee; Claims; No.; Etc.
Patent>Google>Web-Site
TradeMark

Co: FR. A. 177Lu Oxodotreotide's products
This section has no products